Evidence map›Paper›PMID 32952700›Full record

ArticleZdravstveno varstvo2020

Development of an Algorithm for Determining of Genetic Risk at the Primary Healthcare Level - A New Tool for Primary Prevention: A Study Protocol.

Polona Selič, Zalika Klemenc-Ketiš, Erika Zelko, Andrej Kravos, Janez Rifel, Irena Makivić, Antonija Poplas Susič, Špela Tevžič, Metka Cerovič, Borut Peterlin and 1 more

Abstract read
In one paragraph

Article in Zdravstveno varstvo, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Polona SeličUniversity of Ljubljana, Faculty of Medicine, Department of Family Medicine, Poljanski nasip 58, 1000 Ljubljana, Slovenia.
Zalika Klemenc-KetišUniversity of Ljubljana, Faculty of Medicine, Department of Family Medicine, Poljanski nasip 58, 1000 Ljubljana, Slovenia.
Erika ZelkoCommunity Health Centre Ljubljana, Metelkova 9, 1000 Ljubljana, Slovenia.
Andrej KravosUniversity of Maribor, Faculty of Medicine, Department of Family Medicine, Taborska 8, 2000 Maribor, Slovenia.
Janez RifelUniversity of Ljubljana, Faculty of Medicine, Department of Family Medicine, Poljanski nasip 58, 1000 Ljubljana, Slovenia.
Irena MakivićCommunity Health Centre Ljubljana, Metelkova 9, 1000 Ljubljana, Slovenia.
Antonija Poplas SusičCommunity Health Centre Ljubljana, Metelkova 9, 1000 Ljubljana, Slovenia.
Špela TevžičCommunity Health Centre Ljubljana, Metelkova 9, 1000 Ljubljana, Slovenia.
Metka CerovičCommunity Health Centre dr. Adolfa Drolca Maribor, Ulica talcev 9, 2000 Maribor, Slovenia.
Borut PeterlinUniversity Medical Centre Ljubljana, Clinical Institute of Medical Genetics, Šlajmerjeva 4, 1000 Ljubljana, Slovenia.
Nena Kopčavar GučekUniversity of Ljubljana, Faculty of Medicine, Department of Family Medicine, Poljanski nasip 58, 1000 Ljubljana, Slovenia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionFamily history (FH) is an important part of the patients' medical history during preventive management at model family medicine practices (MFMP). It currently includes a one (or two) generational inquiry, predominately in terms of cardiovascular diseases, arterial hypertension, and diabetes, but not of other diseases with a probable genetic aetiology. Beside family history, no application-based algorithm is available to determine the risk level for specific chronic diseases in Slovenia.

methodsA web application-based algorithm aimed at determining the risk level for selected monogenic and polygenic diseases will be developed. The data will be collected in MFMP; approximately 40 overall with a sample including healthy preventive examination attendees (approximately 1,000). Demographic data, a three-generational FH, a medical history of acquired and congenital risk factors for the selected diseases, and other important clinical factors will be documented.

resultsThe results will be validated by a clinical genetic approach based on family pedigrees and the next-generation genetic sequencing method. After the risk of genetic diseases in the Slovenian population has been determined, clinical pathways for acting according to the assessed risk level will be prepared.

conclusionBy means of a public health tool providing an assessment of family predisposition, a contribution to the effective identification of people at increased risk of the selected monogenic and polygenic diseases is expected, lessening a significant public health burden.

Indexed as

family historyfamily medicinegenetic predispositionpedigreepopulation at risk

Identifiers

PMID32952700
PMCPMC7478082

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.